Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GALR3 | O60755 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | PDE3B | Q13370 | 16/20 | 0.57 |
| ▸ | PDE3A | Q14432 | 16/20 | 0.57 |
| ▸ | SLFN12 | Q8IYM2 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 2/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.43 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22910178 | 0.89 | GALR3 (0.68) | GALR3MAPTSMN1; SMN2ALDH1A1GAA | |
| SCHEMBL21241617 | 0.87 | GALR3 (0.65) | GALR3MAPTSMN1; SMN2ALDH1A1GAA | |
| SCHEMBL21241282 | 0.87 | MAPT (0.67) | GALR3MAPTSMN1; SMN2ALDH1A1GAA | |
| SCHEMBL21241615 | 0.87 | GALR3 (0.65) | GALR3MAPTSMN1; SMN2ALDH1A1GAA | |
| SCHEMBL21241281 | 0.86 | GALR3 (0.69) | GALR3MAPTSMN1; SMN2ALDH1A1GAA | |
| SCHEMBL21241019 | 0.85 | PDE3B (0.54) | GALR3MAPTSMN1; SMN2ALDH1A1GAA | |
| SCHEMBL21241246 | 0.85 | MAPT (0.68) | GALR3MAPTSMN1; SMN2ALDH1A1GAA | |
| SCHEMBL22910062 | 0.84 | MAPT (0.64) | GALR3MAPTSMN1; SMN2ALDH1A1GAA | |
| SCHEMBL16156975 | 0.84 | MAPT (0.71) | GALR3MAPTSMN1; SMN2ALDH1A1GAA | |
| SCHEMBL7315454 | 0.84 | MAPT (0.71) | GALR3MAPTSMN1; SMN2ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512056-B2 | Guanidyl-containing P2Y12 receptor antagonist and preparation method and application thereof | ANHUI NEW STAR PHARMACEUTICAL DEVELOPMENT CO., LTD (CN) | 2022-11-29 | — | — | US | claimed |
| US-20210078954-A1 | GUANIDYL-CONTAINING P2Y12 RECEPTOR ANTAGONIST AND PREPARATION METHOD AND APPLICATION THEREOF | ANHUI NEW STAR PHARMACEUTICAL DEVELOPMENT CO., LTD (CN) | 2021-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210078954-A1 | GUANIDYL-CONTAINING P2Y12 RECEPTOR ANTAGONIST AND PREPARATION METHOD AND APPLICATION THEREOF | P2RY12, P2RY13, P2RY11 | GALR3 250/4885MAPT 3866/4885SMN1; SMN2 2584/4885 |
| US-11512056-B2 | Guanidyl-containing P2Y12 receptor antagonist and preparation method and application thereof | P2RY12, P2RY13, P2RY11 | GALR3 250/4885MAPT 3866/4885SMN1; SMN2 2584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.